$AIRS

Airsculpt Technologies, Inc.

CIK:0001870940|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 42,900	$ 44,012	$ 82,289	$ 83,383
Operating expenses:
Cost of service (exclusive of depreciation and amortization)	16,567	17,201	32,155	33,151
Selling, general and administrative	23,421	22,671	46,003	44,439
Depreciation and amortization	2,941	3,246	5,962	6,488
Loss on impairment of long-lived assets	0	108	0	108
Total operating expenses	42,929	43,226	84,120	84,186
(Loss)/income from operations	(29)	786	(1,831)	(803)
Interest expense, net	1,043	1,562	2,241	3,187
Unrealized loss	141	0	3	0
Pre-tax net loss	(1,213)	(776)	(4,075)	(3,990)
Income tax benefit	(101)	(185)	(566)	(552)
Net loss	$ (1,112)	$ (591)	$ (3,509)	$ (3,438)
Loss per share of common stock
Basic (in dollars per share)	$ (0.02)	$ (0.01)	$ (0.05)	$ (0.06)
Diluted (in dollars per share)	$ (0.02)	$ (0.01)	$ (0.05)	$ (0.06)
Weighted average shares outstanding
Basic (in shares)	70,786,163	59,590,033	70,127,093	59,066,400
Diluted (in shares)	70,786,163	59,590,033	70,127,093	59,066,400

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities
Net loss	$ (3,509)	$ (3,438)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	5,962	6,488
Equity-based compensation	1,471	2,591
Non-cash interest expense; amortization of debt costs	273	242
Loss on impairment of long-lived assets	0	108
Changes in assets and liabilities
Taxes receivable	(863)	1,251
Prepaid expense and other current assets	(1,026)	(591)
Other assets	370	4,918
Accounts payable	1,903	(1,461)
Deferred revenue and patient deposits	1,277	(48)
Accrued and other liabilities	(1,825)	(4,208)
Net cash provided by operating activities	4,033	5,852
Cash flows from investing activities
Purchases of property and equipment, net	(279)	(2,166)
Net cash used in investing activities	(279)	(2,166)
Cash flows from financing activities
Payments on term loans	(12,750)	(11,973)
Payments for debt modification	0	(237)
Payments on revolving credit facility	0	(5,000)
Proceeds from public offerings, net	19,566	14,008
Payment of taxes withheld through vested equity-based compensation	(195)	(56)
Other financing activity	0	(474)
Net cash provided by/(used in) financing activities	6,621	(3,732)
Net increase/(decrease) in cash and cash equivalents	10,375	(46)
Cash and cash equivalents
Beginning of period	8,449	8,235
End of period	18,824	8,189
Supplemental disclosure of cash flow information:
Cash paid for interest	2,044	2,948
Cash paid for income taxes, net of refunds	61
Cash paid for income taxes, net of refunds		(1,777)
Supplemental disclosure of non-cash investing information:
Property and equipment included in accounts payable and accrued expenses	$ 12	$ 137

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 18,824	$ 8,449
Taxes receivable	2,362	1,499
Prepaid expenses and other current assets	6,310	5,508
Total current assets	27,496	15,456
Property and equipment, net	24,496	27,814
Other long-term assets	3,000	3,007
Right of use operating lease assets	22,093	22,454
Intangible assets, net	34,462	36,839
Goodwill	81,734	81,734
Total assets	193,281	187,304
Current liabilities
Accounts payable	7,259	5,368
Accrued payroll and benefits	2,573	2,607
Current portion of long-term debt	10,460	5,460
Deferred revenue and patient deposits	3,149	1,871
Accrued and other current liabilities	4,122	5,298
Current operating lease liabilities	7,386	7,298
Total current liabilities	34,949	27,902
Long-term debt, net	33,108	50,585
Deferred tax liability, net	878	878
Long-term operating lease liabilities	19,514	20,227
Total liabilities	88,449	99,592
Commitments and contingent liabilities (Note 9)
Stockholders' equity
Common stock, $0.001 par value; shares authorized - 450,000,000; shares issued and outstanding - 71,518,820 and 64,542,461, respectively	72	64
Additional paid-in capital	149,300	128,315
Accumulated other comprehensive loss	(460)	(96)
Accumulated deficit	(44,080)	(40,571)
Total stockholders' equity	104,832	87,712
Total liabilities and stockholders' equity	$ 193,281	$ 187,304